Supplemental Data from: Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia

Supplemental Data for: Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. JAMA. 2015<br> (Paper available at: PubMed JAMA)<br> <br> Authors: Jeffery M. Klco, M.D., Ph.D.* Christopher A. Miller, Ph.D.*, Malachi Griffith, Ph.D., Allegra Petti, Ph.D., David H. Spencer, M.D., Ph.D., Shamika Ketkar-Kulkarni, M.S., Lukas D. Wartman, M.D., Matthew Christopher, M.D., Ph.D., Tamara L. Lamprecht, B.S., Nicole M. Helton, B.S., Eric J. Duncavage, M.D., Jacqueline E. Payton, M.D., Ph.D., Jack Baty, B.A., Sharon E. Heath, Obi L. Griffith, Ph.D., Dong Shen, Ph.D., Jasreet Hundal, M.S., Gue Su Chang, Ph.D., Robert Fulton, M.S., Michelle O'Laughlin, B.S., Catrina Fronick, B.S., Vincent Magrini, Ph.D., Ryan T. Demeter, B.E., David E. Larson, Ph.D., Shashikant Kulkarni, M.S., Ph.D., Bradley A. Ozenberger, Ph.D., John S. Welch, M.D., Ph.D., Matthew J. Walter, M.D., Timothy A. Graubert, M.D., Peter Westervelt, M.D., Ph.D., Jerald P. Radich, M.D., Daniel C. Link, M.D., Elaine R. Mardis, Ph.D., John F. DiPersio, M.D., Ph.D., Richard K. Wilson, Ph.D., and Timothy J. Ley